BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16784462)

  • 1. PHASE: a novel approach to pharmacophore modeling and 3D database searching.
    Dixon SL; Smondyrev AM; Rao SN
    Chem Biol Drug Des; 2006 May; 67(5):370-2. PubMed ID: 16784462
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
    Xiao Z; Varma S; Xiao YD; Tropsha A
    J Mol Graph Model; 2004 Oct; 23(2):129-38. PubMed ID: 15363455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
    Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
    J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
    Ravindra GK; Achaiah G; Sastry GN
    Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor.
    Vedani A; Dobler M; Lill MA
    J Med Chem; 2005 Jun; 48(11):3700-3. PubMed ID: 15916421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6.
    de Groot MJ; Ackland MJ; Horne VA; Alex AA; Jones BC
    J Med Chem; 1999 May; 42(9):1515-24. PubMed ID: 10229622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.
    Jyrkkärinne J; Windshügel B; Rönkkö T; Tervo AJ; Küblbeck J; Lahtela-Kakkonen M; Sippl W; Poso A; Honkakoski P
    J Med Chem; 2008 Nov; 51(22):7181-92. PubMed ID: 18983136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quo vadis, virtual screening? A comprehensive survey of prospective applications.
    Ripphausen P; Nisius B; Peltason L; Bajorath J
    J Med Chem; 2010 Dec; 53(24):8461-7. PubMed ID: 20929257
    [No Abstract]   [Full Text] [Related]  

  • 10. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA.
    Cramer RD; Cruz P; Stahl G; Curtiss WC; Campbell B; Masek BB; Soltanshahi F
    J Chem Inf Model; 2008 Nov; 48(11):2180-95. PubMed ID: 18956863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore modeling and in silico screening for new KDR kinase inhibitors.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2126-33. PubMed ID: 17306530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the performances of quantitative structure-retention relationship models with different sets of molecular descriptors and databases for high-performance liquid chromatography predictions.
    Wang C; Skibic MJ; Higgs RE; Watson IA; Bui H; Wang J; Cintron JM
    J Chromatogr A; 2009 Jun; 1216(25):5030-8. PubMed ID: 19439313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical database techniques in drug discovery.
    Miller MA
    Nat Rev Drug Discov; 2002 Mar; 1(3):220-7. PubMed ID: 12120506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR.
    Totrov M
    Chem Biol Drug Des; 2008 Jan; 71(1):15-27. PubMed ID: 18069986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational modeling of biologically active molecules using NMR spectra.
    Beger RD
    Drug Discov Today; 2006 May; 11(9-10):429-35. PubMed ID: 16635805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening.
    Cheeseright TJ; Holm M; Lehmann F; Luik S; Göttert M; Melville JL; Laufer S
    J Med Chem; 2009 Jul; 52(14):4200-9. PubMed ID: 19489590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pruned receptor surface models and pharmacophores for three-dimensional database searching.
    Sutherland JJ; O'Brien LA; Weaver DF
    J Med Chem; 2004 Jul; 47(15):3777-87. PubMed ID: 15239656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmarking sets for molecular docking.
    Huang N; Shoichet BK; Irwin JJ
    J Med Chem; 2006 Nov; 49(23):6789-801. PubMed ID: 17154509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the effectiveness of similarity-based virtual screening using nearest-neighbor information.
    Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
    J Med Chem; 2005 Nov; 48(22):7049-54. PubMed ID: 16250664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A self-organizing algorithm for molecular alignment and pharmacophore development.
    Bandyopadhyay D; Agrafiotis DK
    J Comput Chem; 2008 Apr; 29(6):965-82. PubMed ID: 17999384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.